Straus A H, Carter W G, Wayner E A, Hakomori S
Department of Biochemical Oncology, Fred Hutchinson Cancer Research Center.
Exp Cell Res. 1989 Jul;183(1):126-39. doi: 10.1016/0014-4827(89)90423-0.
Cell migration on fibronectin (FN)-coated substrata was studied using 10 cell lines, of which only 2 showed clear enhancement and 1 showed marginal enhancement of cell migration. The migration of the other 7 cell lines was not affected on FN-coated substrata, although they all showed FN-dependent cell adhesion. The migration-enhancing activity of FN was found in the fragment including the cell-adhesion and Hep-2 domains, but not other domains (Hep-1/Fib-1, Gel, Fib-2). No difference in the migration-enhancing effect was seen among FNs from plasma, fibroblasts, or transformed cells. FN-dependent cell migration was inhibited by polyclonal antibodies directed to the C-terminal half region including the cell binding domain, but not by antibodies directed to five other domains. Since these results indicated that FN-mediated cell migration could be controlled by the cell-adhesion domain of FN and its receptor, studies were then focused on the effect of antibodies directed to receptors for FN and collagen, and on the effect of tetrapeptide sequences recognized by these receptors. It was found that (i) cell migration on FN-coated surfaces was specifically inhibited by anti-FN receptor antibody P1F8 but not by anticollagen receptor antibody P1H5; (ii) the migration was strongly inhibited by Arg-Gly-Asp-Ser but not by other oligopeptide sequences. However, the majority of those cell lines not susceptible to FN-dependent cell migration were characterized by having FN receptors and the ability to adhere on FN-coated matrix. Based on these findings, it was concluded that FN-dependent cell migration shares the same recognition mechanism as FN-dependent cell adhesion, but that the majority of cell lines not exhibiting FN-dependent migration still show FN-dependent cell adhesion and express the FN receptor (integrin); i.e., cell migration and adhesion involve the same receptor and the same FN loci, but migration is controlled by still-unidentified cellular factors which determine the susceptibility of the cell to the dynamic function of the FN receptor (integrin) unit.
使用10种细胞系研究了细胞在纤连蛋白(FN)包被的基质上的迁移情况,其中只有2种细胞系显示出细胞迁移明显增强,1种细胞系显示出细胞迁移略有增强。其他7种细胞系的迁移在FN包被的基质上未受影响,尽管它们都表现出FN依赖的细胞黏附。FN的迁移增强活性存在于包含细胞黏附结构域和Hep-2结构域的片段中,而其他结构域(Hep-1/Fib-1、Gel、Fib-2)则没有。血浆、成纤维细胞或转化细胞来源的FN在迁移增强作用上没有差异。针对包括细胞结合结构域的C端半区的多克隆抗体可抑制FN依赖的细胞迁移,但针对其他五个结构域的抗体则无此作用。由于这些结果表明FN介导的细胞迁移可由FN的细胞黏附结构域及其受体控制,因此随后的研究集中在针对FN和胶原蛋白受体的抗体的作用以及这些受体识别的四肽序列的作用上。结果发现:(i)抗FN受体抗体P1F8可特异性抑制细胞在FN包被表面的迁移,而抗胶原蛋白受体抗体P1H5则无此作用;(ii)Arg-Gly-Asp-Ser可强烈抑制迁移,而其他寡肽序列则无此作用。然而,大多数对FN依赖的细胞迁移不敏感的细胞系的特征是具有FN受体并能够黏附在FN包被的基质上。基于这些发现,得出的结论是,FN依赖的细胞迁移与FN依赖的细胞黏附具有相同的识别机制,但大多数未表现出FN依赖迁移的细胞系仍显示出FN依赖的细胞黏附并表达FN受体(整合素);即,细胞迁移和黏附涉及相同的受体和相同的FN位点,但迁移受尚未确定的细胞因子控制,这些细胞因子决定了细胞对FN受体(整合素)单元动态功能的敏感性。